George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.50
Bid: 100.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 102.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

20 Feb 2020 07:00

RNS Number : 5336D
Transense Technologies PLC
20 February 2020
 

20 February 2020

 

Transense Technologies plc

("Transense", the "Company" or the "Group")

Interim results for six months ended 31 December 2019

Transense Technologies plc, the provider of sensor systems for the industrial, mining and transportation markets, reports the results for the six months ended 31 December 2019.

Highlights:

Group revenues of £0.97m (Dec 2018: £0.93m)

iTrack subscription revenue up 50% to £0.66m (Dec 2018: £0.44m)

iTrack subscription revenue run rate at period end up 24% to £1.40m (Jun 2019: £1.12m, Dec 2018: £0.87m)

Joint Collaboration Agreement ("JCA") signed with Bridgestone Corporation in August 2019 by which the iTrack system is offered exclusively by Bridgestone to their customers for large mine haul trucks

Significant working capital, R&D and overhead investment made in preparation for strong growth potential, funded partly by drawdown of US$0.75m (£0.58m) loan under the JCA

Net loss after taxation for the period of £1.19m (Dec 2018: £0.78m) reflecting additional overhead spend

Cash used in operations of £0.54m (Dec 2018: £0.50m)

Net Cash* at end of period of £1.52m (30 June 2019: £2.65m)

Minimum duration of JCA extended post period end until 12 February 2022 at the earliest

* Excludes the impact of IFRS 16 and the Bridgestone Loan of $0.75m

Non Executive Chairman of Transense Technologies, Nigel Rogers, said:

"I am pleased to be taking responsibility as Chairman of Transense at a pivotal time in the commercialisation of our leading technologies. The results for the first half of the financial year reflect the substantial investment in infrastructure, working capital and overhead costs required to take full advantage of our technical excellence, with the financial and commercial support of market leading partners.

 

There has been a transformational change in the scope and commercial reach of the iTrack system, and the business has the potential to deliver a significant breakthrough in market penetration. Our relationships with Bridgestone are strong at all levels, and we anticipate that our collaboration will continue to provide a firm basis for mutual success.

 

As this success becomes apparent, our leading technologies in Surface Acoustic Wave and tyre tread depth probes will increasingly come into focus, as we evaluate investment priorities. There are clear opportunities for technology led growth in each of these areas, and accordingly we look forward with growing confidence."

 

 

For further information please visit www.transense.co.uk or contact:

 

Transense Technologies plc

Nigel Rogers, Chairman

Melvyn Segal, Finance Director

Tel: +44 (0) 1869 238380

finnCap (Nomad and Joint Broker)

Ed Frisby, Giles Rolls (Corporate Finance)

Tim Redfern, Tim Harper (ECM)

Tel: +44 (0)20 7220 0500

 

 

About iTrack 

 

The iTrack Mining system provides real-time data on the condition of the tyres, combined with live tracking of vehicle location and status. Our 24/7 Control Room monitors the pressures and temperatures live, and this information can, for example, be used to ensure tyres do not exceed critical heat thresholds, to detect incorrect load distributions, predict suspension failures and eliminate manual tyre pressure checks. The Directors believe that these benefits maximise the hours a truck is working (Truck Uptime) and improve productivity by minimising maintenance requirements and using data to identify underperforming trucks. www.trans-logik.com/itrack-2/ 

 

About Transense Technologies 

 

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. The Directors believe that Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer advantages over legacy wireless sensor systems. Transense is targeting the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its trading divisions, Translogik and SAWSense. www.transense.co.uk 

 

Transense's shares are admitted to trading on AIM (AIM: TRT). 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014. 

 

 

 

Transense Technologies plc

Chairman's Statement

I am pleased to be taking responsibility as Chairman of Transense at a pivotal time in the commercialisation of our leading technologies in iTrack and Surface Acoustic Wave sensing. The results for the first half of the financial year reflect the substantial investment in infrastructure, working capital and overhead costs required to take full advantage of our technical excellence, with the financial and commercial support of market leading partners.

 

 

Business strategy

The business strategy of the Group remains to develop innovative sensing solutions across a range of applications, which are commercialised either through the launch of products and services to customers or by forming strategic alliances with partner organisations. Value is realised through a combination of commercial income, royalties, licensing income and capital gains on disposals.

 

Operational review

SAWSense

SAWSense is a leader in the development of Surface Acoustic Wave ("SAW") wireless, batteryless, sensor systems that offer significant advantages over legacy systems in common use.

In July 2016, SAWSense entered into a significant licensing agreement with General Electric Company ("GE") for the use of patented, wireless, passive SAW technology in GE Aviation's T901-GE-900 engine. This has been selected by the U.S. Army for the Engineering and Manufacturing Development ("EMD") phase of the Improved Turbine Engine Program ("ITEP"), the U.S. Army's programme to replace more than 6,000 engines in its current fleet of Boeing AH-64 Apache and Sikorsky UH60 Black Hawk helicopters, expected to commence around 2023 reaching full volume in 2026.

This project has now been extended into the GE supply chain, where we are engaged with first tier global manufacturing partners of GE to support the production process, and this work is progressing on schedule.

Our relationship with GE continues to develop, with several new applications under review in co-operation with GE Research in Niskayuna, New York. These extend beyond avionics into marine, industrial and power generation technologies.

 

The agreement we have with GE is not exclusive and we have the opportunity to enter into other similar relationships. During the period under review, work continued in partnership with the Electronic Materials and Devices Group of the University of Southampton to develop SAW technology for the real time monitoring of temperature and strain on the inner and outer shells of Liquid Nitrogen Gas tanks in situ. This project is funded by Lloyd's Register Foundation, and is intended to pave the way towards providing early warnings of structural defects, predicting failures, and thus obviating unnecessary dry dock inspections that are both costly and dangerous. The project is anticipated to have a duration of two and a half years, and during the period grant funding of £0.12m was received to support this activity.

During the period there was further activity on projects in the automotive field, covering recreational vehicles, Indy car and Formula 1, although no significant breakthrough into full production vehicles is evident at the current time.

Translogik

Translogik has developed a range of products and services for tyre pressure and temperature monitoring of mining haul trucks marketed under the name iTrack. The division also markets a range of tread depth probes and associated monitoring systems for use in the passenger car, bus, truck and OTR sectors.

Translogik - iTrack

iTrack has continued to achieve increased market penetration as a stand alone system in the period, with a 50% increase in monthly subscription revenues compared with the first half of last year.

Even more significant, however, was the signing of the Joint Collaboration Agreement ("JCA") with Bridgestone Corporation ("Bridgestone") in August 2019, for an initial eighteen month period. Bridgestone is the world's largest producer of tyres and other rubber products with annual revenues in excess of £24bn and is the global market leader in the manufacture and sale of tyres.

Under the JCA, Bridgestone has agreed to offer the iTrack system exclusively as a mining tyre monitoring system for the largest mine haul trucks, and the Company has agreed that it will not contract with any other tyre manufacturer for this category of tyres.

Since the commencement of the JCA, Bridgestone affiliate agreements have been signed in many key territories, facilitating pre-sales engagement with major clients worldwide. This activity has produced sales opportunities at an unprecedented level, and many new trials are underway. The typical sales cycle in this marketplace extends for a number of months prior to adoption, and accordingly the JCA has not yet generated significant subscription income. There are considerable costs associated with the generation of client engagement, however, including building our sales, customer support and technical teams, opening a new London office to co-ordinate these activities, and extensive overseas travel. These additional costs have been part funded by direct support and loans from Bridgestone under the terms of the JCA, and the impact on reported earnings in the current period was approximately £0.40m.

Customer reaction has been very positive, indicating scope to increase iTrack adoption significantly in the second half of the year and beyond. Furthermore, the minimum term of the JCA was recently extended by a further twelve months until not earlier than February 2022.

The JCA also contains an undertaking by Transense not to have discussions with any other party in relation to any transaction of a merger, acquisition or joint venture nature in respect of the iTrack business and this undertaking was recently extended to expire on 30 April 2020.

Translogik - probes

Our range of tyre tread depth probes is compatible with the tyre management systems of a number of the world's leading tyre producers. Revenues from this range reduced in the second half of the last financial year, which was believed to have been a consequence of reduced marketing activity at that time. This was addressed in the early months of this financial year, and a return to modest growth is evident, with revenues of £0.25m recovering to a similar level as the first half of last year, and importantly a noticeable increase in enquiries.

Work is ongoing to make further enhancements to the current probes and provide a modular version.

 

Financial results

 

Revenues for the six months were broadly in line with the corresponding period last year at £0.97m (Dec 2018: £0.93m), with subscription revenues generated by users of the iTrack system increased by 50% to £0.66m (Dec 2018: £0.44m). The annualised subscription run rate at the end of the period was £1.4m representing an increase of 24% since the financial year end and a 60% increase compared with the run rate at last year's H1 period end (Jun 19: £1.1m and Dec 18: £0.9m). There were further units in the field awaiting deployment by customers and with all units deployed the annualised run rate increases to £1.7m.

We anticipate these revenues have the potential to grow strongly over the remainder of 2020 and throughout 2021 as the iTrack installed base expands, especially as a result of the JCA.

Operating expenses in the period were £2.08m (Dec 2018: £1.69m) as a consequence of the incremental overheads associated with the ramp up of iTrack. The resulting net loss before taxation from continuing operations was slightly higher than the comparative period at £1.19m (Dec 2018: £0.91m).

The total comprehensive loss for the period amounted to £1.19m (Dec 2018: £0.78m), reflecting a tax credit of £nil (Dec 2018: £0.12m).

The board continues to keep under careful review the expected outturn for the financial year ending 30 June 2020, and, in particular, the likely timing of conversion of an unprecedented level of customer enquires into deployed units that will be the subject of sale or subscription agreements. It is increasingly likely that units will be deployed solely on a subscription model, with significant longer term benefits, but to the detriment of short term income recognition. Furthermore, the directors consider that it would be inappropriate to cut back overhead expenditure at an expected inflexion point in the conversion of customer demand.

 

Accordingly, the board has revised downwards its expectations for the current financial year to reflect these market dynamics, whilst being committed to delivering increases in the future growth trajectory in the following financial periods.

Financial position and cash flow

Operating cash outflow before movements in working capital increased slightly to £0.76m compared to the corresponding period in the last financial year (Dec 2018: £0.52m). Cash used in operations for the period increased marginally to £0.54m (Dec 2018: £0.50m).

The net investment in fixed assets for iTrack contracts in the period amounted to £0.26m (December 2018: £0.20m) and as the iTrack installed base increases there will continue to be a need to invest in fixed assets. During the period there was further fixed asset investment of £0.06m in the fit out and equipping of a new London office to co-ordinate worldwide activities on iTrack.

The Company also capitalised ongoing development expenditure on iTrack totaling £0.18m (Dec 2018: £0.11m).

The Company closed the period with net cash of £1.52m (30 June 2019: £2.65m) which excludes the impact of IFRS 16 and the Bridgestone Loan of $0.75m.

The board has assessed the financial and operational needs of the business over the forthcoming twelve months covering a broad range of potential outcome scenarios. In each case, the directors are satisfied that the Company has access to adequate sources of finance.

 

Accordingly, the Board consider we will have sufficient resources to continue in operational existence for the foreseeable future.

 

Outlook and prospects

The financial year thus far has seen transformational change in the scope and commercial reach of the iTrack system, and the business has the potential to deliver a significant breakthrough in market penetration. Whilst the board has revised downwards its expectations for the current financial year to reflect our current market dynamics, the board remains committed to delivering increases in growth trajectory in the following financial periods. Our relationships with Bridgestone are strong at all levels, and we anticipate that our collaboration will continue to provide a firm basis for mutual success.

 

As this success becomes apparent, our leading technologies in Surface Acoustic Wave and tyre tread depth probes will increasingly come into focus, as we evaluate investment priorities. There are clear opportunities for technology led growth in each of these areas, and accordingly we look forward with growing confidence.

 

 

Nigel RogersChairman20 February 2020

 

 

 

 

 

Transense Technologies plc

 

 

 

 

 

 

Condensed Consolidated Statement of Comprehensive Income

 

 

 

 

 

 

 

 

 

 

 

 

Half year to

 

Half year to

 

Full Year

 

 

 

 

31 Dec 19

 

31 Dec 18

 

30 Jun 19

 

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

 

£'000

 

£'000

 

£'000

 

 

Continuing operations

 

 

 

 

 

 

 

Revenue

 

965

 

933

 

2,226

 

 

Cost of sales

 

(193)

 

(202)

 

(435)

 

 

Gross profit

 

772

 

731

 

1,791

 

 

 

 

 

 

 

 

 

 

 

Administrative expenses

(2,080)

 

(1,686)

 

(3,603)

 

 

 

 

 

 

 

 

 

 

Operating loss

 

(1,308)

 

(955)

 

(1,812)

 

 

 

 

 

 

 

 

 

 

 

Interest receivable

 

4

 

-

 

2

 

 

Interest payable

 

(4)

 

-

 

-

 

 

Other income

 

118

 

49

 

79

 

 

Loss before taxation

(1,190)

 

(906)

 

(1,731)

 

 

 

 

 

 

 

 

 

 

 

Taxation

 

-

 

124

 

266

 

 

 

 

 

 

 

 

 

 

 

Loss for the year

(1,190)

 

(782)

 

(1,465)

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income:

 

 

 

 

 

 

 

 

Exchange difference on translating foreign operations

 

18

 

2

 

2

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income for the year

 

18

 

2

 

2

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive income for the year attributable to the equity holders of the parent

 

(1,172)

 

(780)

 

(1,463)

 

 

           
 

 

Transense Technologies plc

 

 

 

 

 

Condensed Consolidated Statement of Financial Position

 

 

 

 

 

 

 

 

 

 

31 Dec 19

 

31 Dec 18

 

30 Jun 19

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

£'000

 

£'000

 

£'000

Non current assets

 

 

 

 

 

Property, plant and equipment

909

 

510

 

529

Intangible assets

 

1,033

 

860

 

946

 

 

1,942

 

1,370

 

1,475

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Inventory

730

 

575

 

566

Corporation tax receivable

-

 

129

 

-

Trade and other receivables

988

 

729

 

789

Cash and cash equivalents

1,519

 

843

 

2,647

 

 

3,237

 

2,276

 

4,002

 

 

 

 

 

 

 

Total assets

 

5,179

 

3,646

 

5,477

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

(1,286)

 

(412)

 

(604)

Current tax liabilities

(63)

 

(68)

 

(55)

Provisions

 

(50)

 

(70)

 

(70)

Total liabilities

 

(1,399)

 

(550)

 

(729)

 

 

 

 

 

 

 

Non current liabilities

 

(204)

 

-

 

-

 

 

 

 

 

 

 

Net assets

 

3,576

 

3,096

 

4,748

 

 

 

 

 

 

 

Capital and reserves

 

 

 

 

 

Share capital

 

5,451

 

5,025

 

5,451

Share premium

 

2,591

 

682

 

2,591

Share based payments

 

41

 

41

 

41

Translation reserve

 

41

 

23

 

23

Accumulated reserve/(deficit)

 

(4,548)

 

(2,675)

 

(3,358)

Shareholders' funds

3,576

 

3,096

 

4,748

 

 

 

 

 

 

 

 

 

 

Transense Technologies plc

Condensed Consolidated Statement of Changes in Equity (Unaudited)

 

 

 

 

 

Issued share capital

Share premium account

Translation Reserve

Share based payments

Accumulated deficit

Total equity

 

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

 

Balance at 1 July 2018

5,025

682

21

41

(1,893)

3,876

 

 

 

 

 

 

 

 

Comprehensive income for the year:

 

 

Loss for the period

-

-

-

-

(1,465)

(1,465)

Other comprehensive income for the year:

 

Currency movement on subsidiary reserves

-

-

2

-

-

2

Total Comprehensive income for the year:

-

-

2

-

(1,465)

(1,463)

Shares issued and share premium

426

1,909

-

-

-

2,335

 

 

 

 

 

 

 

 

Balance at 30 June 2019

5,451

2,591

23

41

(3,358)

4,748

 

 

 

 

 

 

 

 

Comprehensive income for the period:

 

Loss for the period

-

-

-

 

(1,190)

(1,190)

Other comprehensive income for the period:

 

Translation of foreign entity

-

-

18

 

-

18

Total Comprehensive income for the period:

-

-

18

-

-

1,172

 

 

 

 

 

 

 

 

Balance at 31 December 2019

5,451

2,591

41

41

(4,548)

3,576

 

 

 

 

 

 

 

 

             

 

 

 

Transense Technologies plc

 

 

 

 

 

Condensed Consolidated Statement of Cash Flows

 

 

 

 

 

 

 

Half year to

 

Half year to

 

Full year to

 

 

31 Dec 19

 

31 Dec 18

 

30 Jun 19

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

£'000

 

£'000

 

£'000

Cash flow from operating activities

 

 

 

 

 

Loss for the period

(1,190)

 

(782)

 

(1,465)

Adjustments for

 

 

 

 

 

Taxation

-

 

(124)

 

(266)

Interest receivable

(4)

 

-

 

(2)

Interest payable

4

 

-

 

-

Depreciation of property, plant and equipment

211

 

178

 

369

Amortisation and impairment of intangible assets

216

 

211

 

396

Share based payments

-

 

-

 

-

 

 

 

 

 

 

Operating cash flows before movements in working capital

(763)

 

(517)

 

(968)

 

 

 

 

 

 

 

Change in receivables

(199)

 

(160)

 

(91)

Change in payables

583

 

68

 

247

Change in inventories

(164)

 

110

 

119

Cash used in operations

(543)

 

(499)

 

(693)

Taxation recovered

-

 

124

 

266

Net cash used in operations

(543)

 

(375)

 

(427)

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Interest received

4

 

-

 

2

Interest paid

(4)

 

-

 

-

Acquisition of property, plant & equipment

(300)

 

(215)

 

(424)

Acquisition of intangible assets

(303)

 

(161)

 

(433)

Net cash used in investing activities

(603)

 

(376)

 

(855)

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Proceeds from issue of equity share capital

-

 

-

 

2,335

 

 

 

 

 

 

Net cash used for financing activities

-

 

-

 

2,335

 

 

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

(1,146)

 

(751)

 

1,053

Unrealised currency translation gain

18

 

2

 

2

Cash and cash equivalents at beginning of period

2,647

 

1,592

 

1,592

Cash and cash equivalents at end of period

1,519

 

843

 

2,647

 

 

 

 

 

 

 

 

 

 

Notes to the Interim results for the six months to 31 December 2019

 

1 Reporting Entity

Transense Technologies plc ("the Company") is a company incorporated in the United Kingdom under the Companies Act 2006. These condensed consolidated interim financial statements of the Company as at and for the six months ended 30 December 2019 comprises the Company and its subsidiaries (together referred to as "the Group" and individually as "Group entities"). These condensed consolidated interim financial statements are presented in pounds sterling, rounded to the nearest thousand.

 

The consolidated financial statements of the Group are available upon request from the Company's registered office or at www.transense.co.uk

 

These condensed consolidated interim financial statements are unaudited.

 

2 Accounting policies

The Condensed Consolidated Financial Statements for the half yearly report for the 6 months ended 31 December 2019 have been prepared using accounting policies and methods of computation consistent with those set in Transense Technologies plc's Annual Report and Financial Statements for the year ended 30 June 2019. There has been no change to any accounting policy from the date of that repot, except for the Group has now implemented IFRS 16 - Leases.

 

The Group has transitioned to IFRS 16 as at 1 July 2019 and it has transitioned the leases previously accounted for as operating leases under IAS 17 using the Modified Retrospective Approach.

 

The Group has assessed its leases that were previously accounted for under IAS 17, recognising the discounted asset at the date of transition as a Right of Use asset within tangible fixed assets and the associated liability within trade and other payables.

 

Following the transition to IFRS 16, a right of use asset (and associated liability) of £0.29m (£0.20m in non current liabilities and £0.09m in current liabilities) was recognised. In H1 2020, there has been £0.03m of depreciation against the assets and approximately £4,000 of interest incurred associated with the unwind of the discount on the liability.

 

3 Earnings per share

 

 

31 December 2019

31 December 2018

30 June 2019

 

Shares

Shares

Shares

Weighted average number of shares

 

 

 

Issued at start of period

16,307,282

12,048,948

12,048,948

Effect of shares issued in period

-

-

1,135,633

Weighted average number of shares at end of period

16,307,282

12,048,948

13,184,581

 

 

 

 

Basic Earnings per share

(7.30p)

(6.49p)

(11.11p)

 

 

4 Revenue

Revenue

Half year to

Half year to

Full year to

 

31 Dec 19

31 Dec 18

30 Jun 19

 

(Unaudited)

(Unaudited)

(Audited)

 

£'000

£'000

£'000

Chile

325

373

670

Australia

237

186

398

Rest of the World

212

76

192

North America

129

203

743

UK & Europe

62

95

192

Japan

-

-

31

Total

965

933

2,226

5 Trade and other payables

Included in trade and other payables is a loan from Bridgestone of $0.75m (£0.58) which could become repayable in the next 12 months.

6 Going concern

The interim financial information has been prepared on a going concern basis, which assumes that the Company will have adequate resources to continue in operational existence for the foreseeable future.

7 Corporation tax and deferred tax

The Company is entitled to a Corporation Tax credit in respect of expenditure on Research and Development and this is recognised in the accounts on the basis that the credit is received before finalising the accounts.

The Group has tax losses, in the sum of £22m which, subject to agreement by HM Revenue and Customs, are available for offset against future profits of the same trade. There is no expiry date for tax losses however there is an annual restriction of £5m plus half of the surplus above £5m. An appropriate asset will be recognised when the Group can demonstrate a reasonable expectation of sufficient taxable profits to utilise the temporary differences.

 

Accordingly, no deferred tax asset is recognised in these financial statements in respect of trading losses to date.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR FFFIFFFIALII
Date   Source Headline
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company
26th Sep 20233:37 pmRNSDirector/PDMR Shareholding
25th Sep 202311:00 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSFinal Results & Investor Presentation
22nd Sep 20239:25 amRNSHolding(s) in Company
31st Aug 20235:00 pmRNSTotal Voting Rights
29th Aug 20238:30 amRNSTransaction in Own Shares & TVR
23rd Aug 20237:00 amRNSNotice of Results & Investor Presentation
16th Aug 202310:03 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSYear End Trading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20234:24 pmRNSTransaction in own shares & TVR
19th Jun 20234:29 pmRNSHolding(s) in Company
16th Jun 20235:57 pmRNSTransaction in own shares & TVR
5th Jun 20237:00 amRNSSAW: Extension of scope of licence agreement
2nd Jun 20232:36 pmRNSTransaction in own shares & TVR
31st May 20235:00 pmRNSTotal Voting Rights
3rd May 20237:00 amRNSNew Automotive eDrive Business Contract
2nd May 202312:48 pmRNSAppointment of Non-Executive Director
2nd May 202310:23 amRNSTransaction in own shares & TVR
31st Mar 20235:00 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSGrant of share options to Director and employees
20th Mar 20238:49 amRNSTransaction in Own Shares & TVR
20th Mar 20237:00 amRNSTransaction in Own Shares & TVR
13th Mar 20232:49 pmRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.